Drugs / FB1006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05923905 | Jan 2023 → Sep 2027 expected | — | Peking University Third Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FB1006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05923905 ↗ |